-
Tezepelumab, sold
under the
brand name Tezspire, is a
human monoclonal antibody used for the
treatment of asthma.
Tezepelumab blocks thymic stromal lymphopoietin...
- November. In December, the FDA
approved Amgen and AstraZeneca's
Tezspire (
tezepelumab) for
severe asthma. The FDA also
approved Amgen's
Otezla for
adults with...
-
allergy shots and a
monoclonal antibody Tezepelumab.
Among the tests, the parti****nts
given the shot with the
Tezepelumab had
greater results than the placebo...
- R03DX08
Reslizumab R03DX09
Mepolizumab R03DX10
Benralizumab R03DX11
Tezepelumab "ATC (Anatomical
Therapeutic Chemical classification System) – Synopsis"...
- 24 May 2009. "Tezspire-
tezepelumab-ekko injection, solution". DailyMed.
Retrieved 24
December 2021. "Tezspire (
tezepelumab)
approved in the US for severe...
- lymphoma".
Anticancer Research. 33 (1): 85–95. PMID 23267131. "Tezspire-
tezepelumab-ekko injection, solution". DailyMed. 17
December 2021.
Archived from...
-
include omalizumab, mepolizumab, reslizumab, benralizumab,
dupilumab and
tezepelumab.
Omalizumab binds to free
human immunoglobulin (IgE) to
reduce IgE level...
- Oxelumab§
Pamrevlumab Placulumab Relatlimab†
Sarilumab Sifalimumab Tabalumab Tezepelumab Ulocuplumab Varlilumab Immune activation:
Ipilimumab Durvalumab Nivolumab...
- Oxelumab§
Pamrevlumab Placulumab Relatlimab†
Sarilumab Sifalimumab Tabalumab Tezepelumab Ulocuplumab Varlilumab Immune activation:
Ipilimumab Durvalumab Nivolumab...
